Browse by Changes
Summary of Changes – 1 July 2025
Page last updated: 1 July 2025
Previous versions of the Summary of Changes are available in PDF in the Publications Archive .
- Additions
- Deletions
- Alterations
- Supply Only
- Advance Notices
- Palliative Care
- Highly Specialised Drugs Program (Private Hospital)
- Highly Specialised Drugs Program (Public Hospital)
- Highly Specialised Drugs Program (Community Access)
- Repatriation Pharmaceutical Benefits
- Efficient Funding of Chemotherapy (Private Hospital)
- Efficient Funding of Chemotherapy (Public Hospital)
- Related Pharmaceutical Benefits for Public Hospital use
General Pharmaceutical Benefits
Additions
Addition – Item
| 14869N | AZITHROMYCIN, azithromycin 500 mg tablet, 3 (Azithromycin Tablets, USP 500 mg (Precision Dose, USA)) |
| 14870P | AZITHROMYCIN, azithromycin 500 mg tablet, 3 (Azithromycin Tablets, USP 500 mg (Precision Dose, USA)) |
| 14875X | DROSPIRENONE, drospirenone 4 mg tablet [24] (&) inert substance tablet [4], 28 (Slinda) |
| 14852Q | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices (Nepexto) |
| 14864H | FARICIMAB, faricimab 6 mg/0.05 mL intraocular injection, 0.05 mL syringe (Vabysmo) |
| 14873T | FARICIMAB, faricimab 6 mg/0.05 mL intraocular injection, 0.05 mL syringe (Vabysmo) |
| 14868M | IVOSIDENIB, ivosidenib 250 mg tablet, 60 (Tibsovo) |
| 14857Y | METHYLPHENIDATE, methylphenidate hydrochloride 18 mg modified release tablet, 60 (Concerta (Switzerland)) |
| 14861E | METHYLPHENIDATE, methylphenidate hydrochloride 18 mg modified release tablet, 30 (Concerta (Switzerland)) |
| 14874W | METHYLPHENIDATE, methylphenidate hydrochloride 27 mg modified release tablet, 30 (Concerta (Switzerland)) |
| 14858B | METHYLPHENIDATE, methylphenidate hydrochloride 36 mg modified release tablet, 30 (Concerta (Switzerland)) |
| 14862F | METHYLPHENIDATE, methylphenidate hydrochloride 36 mg modified release tablet, 60 (Concerta (Switzerland)) |
| 14853R | METHYLPHENIDATE, methylphenidate hydrochloride 54 mg modified release tablet, 30 (Concerta (Switzerland)) |
| 14871Q | METHYLPHENIDATE, methylphenidate hydrochloride 54 mg modified release tablet, 60 (Concerta (Switzerland)) |
| 14854T | NAPROXEN, naproxen 125 mg/5 mL oral liquid, 474 mL (Pediapharm Naproxen Suspension 25 mg/mL (Medexus Pharma, Canada)) |
| 14851P | RIBOCICLIB, ribociclib 200 mg tablet, 21 (Kisqali) |
| 14863G | RIBOCICLIB, ribociclib 200 mg tablet, 42 (Kisqali) |
Addition – Brand
| 10219W | ARIPENA, RA– ARIPIPRAZOLE , aripiprazole 400 mg modified release injection [1 vial] (&) inert substance diluent [2 mL vial], 1 pack |
| 11198J | Nepexto, GQ– ETANERCEPT , etanercept 50 mg/mL injection, 4 x 1 mL pen devices |
| 11201M | Nepexto, GQ– ETANERCEPT , etanercept 50 mg/mL injection, 4 x 1 mL pen devices |
| 11202N | Nepexto, GQ– ETANERCEPT , etanercept 50 mg/mL injection, 4 x 1 mL pen devices |
| 11215G | Nepexto, GQ– ETANERCEPT , etanercept 50 mg/mL injection, 4 x 1 mL pen devices |
| 11218K | Nepexto, GQ– ETANERCEPT , etanercept 50 mg/mL injection, 4 x 1 mL pen devices |
| 11221N | Nepexto, GQ– ETANERCEPT , etanercept 50 mg/mL injection, 4 x 1 mL pen devices |
| 11222P | Nepexto, GQ– ETANERCEPT , etanercept 50 mg/mL injection, 4 x 1 mL pen devices |
| 13687J | Nepexto, GQ– ETANERCEPT , etanercept 50 mg/mL injection, 4 x 1 mL pen devices |
| 13697X | Nepexto, GQ– ETANERCEPT , etanercept 50 mg/mL injection, 4 x 1 mL pen devices |
| 13708L | Nepexto, GQ– ETANERCEPT , etanercept 50 mg/mL injection, 4 x 1 mL pen devices |
| 13774Y | Nepexto, GQ– ETANERCEPT , etanercept 50 mg/mL injection, 4 x 1 mL pen devices |
| 1964J | Nepexto, GQ– ETANERCEPT , etanercept 50 mg/mL injection, 4 x 1 mL pen devices |
| 3447K | Nepexto, GQ– ETANERCEPT , etanercept 50 mg/mL injection, 4 x 1 mL pen devices |
| 3450N | Nepexto, GQ– ETANERCEPT , etanercept 50 mg/mL injection, 4 x 1 mL pen devices |
| 9455P | Nepexto, GQ– ETANERCEPT , etanercept 50 mg/mL injection, 4 x 1 mL pen devices |
| 9456Q | Nepexto, GQ– ETANERCEPT , etanercept 50 mg/mL injection, 4 x 1 mL pen devices |
| 9457R | Nepexto, GQ– ETANERCEPT , etanercept 50 mg/mL injection, 4 x 1 mL pen devices |
| 9458T | Nepexto, GQ– ETANERCEPT , etanercept 50 mg/mL injection, 4 x 1 mL pen devices |
| 9459W | Nepexto, GQ– ETANERCEPT , etanercept 50 mg/mL injection, 4 x 1 mL pen devices |
| 9460X | Nepexto, GQ– ETANERCEPT , etanercept 50 mg/mL injection, 4 x 1 mL pen devices |
| 9461Y | Nepexto, GQ– ETANERCEPT , etanercept 50 mg/mL injection, 4 x 1 mL pen devices |
| 9462B | Nepexto, GQ– ETANERCEPT , etanercept 50 mg/mL injection, 4 x 1 mL pen devices |
| 5262Y | FILOSIR, NM– FINGOLIMOD , fingolimod 500 microgram capsule, 28 |
| 14005D | APOHEALTH Urinary Tract Antibacterial, TX– METHENAMINE HIPPURATE , methenamine hippurate 1 g tablet, 100 |
| 14005D | Chemists' Own Urinary Tract Antibacterial, RW– METHENAMINE HIPPURATE , methenamine hippurate 1 g tablet, 100 |
| 3124K | APOHEALTH Urinary Tract Antibacterial, TX– METHENAMINE HIPPURATE , methenamine hippurate 1 g tablet, 100 |
| 3124K | Chemists' Own Urinary Tract Antibacterial, RW– METHENAMINE HIPPURATE , methenamine hippurate 1 g tablet, 100 |
| 12192Q | APO-Rivaroxaban, TX– RIVAROXABAN , rivaroxaban 2.5 mg tablet, 60 |
| 12197Y | APO-Rivaroxaban, TX– RIVAROXABAN , rivaroxaban 2.5 mg tablet, 60 |
| 13366L | APO-Rivaroxaban, TX– RIVAROXABAN , rivaroxaban 2.5 mg tablet, 60 |
| 11633G | APO-Rivaroxaban, TX– RIVAROXABAN , rivaroxaban 10 mg tablet, 30 |
| 11633G | Rivarelto, XW– RIVAROXABAN , rivaroxaban 10 mg tablet, 30 |
| 13521P | APO-Rivaroxaban, TX– RIVAROXABAN , rivaroxaban 10 mg tablet, 30 |
| 13521P | Rivarelto, XW– RIVAROXABAN , rivaroxaban 10 mg tablet, 30 |
| 9466F | APO-Rivaroxaban, TX– RIVAROXABAN , rivaroxaban 10 mg tablet, 15 |
| 9467G | APO-Rivaroxaban, TX– RIVAROXABAN , rivaroxaban 10 mg tablet, 30 |
| 9467G | Rivarelto, XW– RIVAROXABAN , rivaroxaban 10 mg tablet, 30 |
| 9469J | APO-Rivaroxaban, TX– RIVAROXABAN , rivaroxaban 10 mg tablet, 15 |
| 13463N | APO-Rivaroxaban, TX– RIVAROXABAN , rivaroxaban 15 mg tablet, 28 |
| 13463N | Rivarelto, XW– RIVAROXABAN , rivaroxaban 15 mg tablet, 28 |
| 2160Q | APO-Rivaroxaban, TX– RIVAROXABAN , rivaroxaban 15 mg tablet, 42 |
| 2160Q | Rivarelto, XW– RIVAROXABAN , rivaroxaban 15 mg tablet, 42 |
| 2691P | APO-Rivaroxaban, TX– RIVAROXABAN , rivaroxaban 15 mg tablet, 28 |
| 2691P | Rivarelto, XW– RIVAROXABAN , rivaroxaban 15 mg tablet, 28 |
| 13462M | APO-Rivaroxaban, TX– RIVAROXABAN , rivaroxaban 20 mg tablet, 28 |
| 13462M | Rivarelto, XW– RIVAROXABAN , rivaroxaban 20 mg tablet, 28 |
| 2268J | APO-Rivaroxaban, TX– RIVAROXABAN , rivaroxaban 20 mg tablet, 28 |
| 2268J | Rivarelto, XW– RIVAROXABAN , rivaroxaban 20 mg tablet, 28 |
| 11123K | Omtralo, NM– SACUBITRIL + VALSARTAN , sacubitril 24.3 mg + valsartan 25.7 mg tablet, 56 |
| 11123K | Sacubitril/Valsartan Alphapharm, FY– SACUBITRIL + VALSARTAN , sacubitril 24.3 mg + valsartan 25.7 mg tablet, 56 |
| 13570F | Omtralo, NM– SACUBITRIL + VALSARTAN , sacubitril 24.3 mg + valsartan 25.7 mg tablet, 56 |
| 13570F | Sacubitril/Valsartan Alphapharm, FY– SACUBITRIL + VALSARTAN , sacubitril 24.3 mg + valsartan 25.7 mg tablet, 56 |
| 11131W | Omtralo, NM– SACUBITRIL + VALSARTAN , sacubitril 48.6 mg + valsartan 51.4 mg tablet, 56 |
| 11131W | Sacubitril/Valsartan Alphapharm, FY– SACUBITRIL + VALSARTAN , sacubitril 48.6 mg + valsartan 51.4 mg tablet, 56 |
| 13511D | Omtralo, NM– SACUBITRIL + VALSARTAN , sacubitril 48.6 mg + valsartan 51.4 mg tablet, 56 |
| 13511D | Sacubitril/Valsartan Alphapharm, FY– SACUBITRIL + VALSARTAN , sacubitril 48.6 mg + valsartan 51.4 mg tablet, 56 |
| 11122J | Omtralo, NM– SACUBITRIL + VALSARTAN , sacubitril 97.2 mg + valsartan 102.8 mg tablet, 56 |
| 11122J | Sacubitril/Valsartan Alphapharm, FY– SACUBITRIL + VALSARTAN , sacubitril 97.2 mg + valsartan 102.8 mg tablet, 56 |
| 13445P | Omtralo, NM– SACUBITRIL + VALSARTAN , sacubitril 97.2 mg + valsartan 102.8 mg tablet, 56 |
| 13445P | Sacubitril/Valsartan Alphapharm, FY– SACUBITRIL + VALSARTAN , sacubitril 97.2 mg + valsartan 102.8 mg tablet, 56 |
Addition – Equivalence Indicator
| 10219W | Abilify Maintena, LU– ARIPIPRAZOLE , aripiprazole 400 mg modified release injection [1 vial] (&) inert substance diluent [2 mL vial], 1 pack |
| 14791L | Slinda, HB– DROSPIRENONE , drospirenone 4 mg tablet [24] (&) inert substance tablet [4], 4 x 28 |
| 14737P | Vabysmo, RO– FARICIMAB , faricimab 6 mg/0.05 mL intraocular injection, 0.05 mL vial |
| 14738Q | Vabysmo, RO– FARICIMAB , faricimab 6 mg/0.05 mL intraocular injection, 0.05 mL vial |
| 1658G | Phebra Naproxen Suspension, FF– NAPROXEN , naproxen 125 mg/5 mL oral liquid, 474 mL |
| 14844G | Ozempic, NO– SEMAGLUTIDE , semaglutide 0.68 mg/mL injection, 1 x 3 mL pen device |
| 14846J | Ozempic, NO– SEMAGLUTIDE , semaglutide 0.68 mg/mL injection, 1 x 3 mL pen device |
Addition – Note
| 8200N | AZITHROMYCIN, azithromycin 500 mg tablet, 2 (APO-Azithromycin, AZITHROMYCIN-WGR, Azithromycin Sandoz, Azithromycin Viatris, ZITHRO, Zithromax) |
| 8336R | AZITHROMYCIN, azithromycin 500 mg tablet, 2 (APO-Azithromycin, AZITHROMYCIN-WGR, Azithromycin Sandoz, Azithromycin Viatris, ZITHRO, Zithromax) |
| 14791L | DROSPIRENONE, drospirenone 4 mg tablet [24] (&) inert substance tablet [4], 4 x 28 (Slinda) |
| 1954W | ETANERCEPT, etanercept 25 mg injection [4 vials] (&) inert substance diluent [4 x 1 mL syringes], 1 pack (Enbrel) |
| 1964J | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices (Enbrel, Nepexto) |
| 1963H | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes (Enbrel) |
| 2387P | METHYLPHENIDATE, methylphenidate hydrochloride 18 mg modified release tablet, 30 (Concerta, METHYLPHENIDATE-TEVA XR, Methylphenidate XR ARX) |
| 2172H | METHYLPHENIDATE, methylphenidate hydrochloride 27 mg modified release tablet, 30 (Concerta, METHYLPHENIDATE-TEVA XR, Methylphenidate XR ARX) |
| 2388Q | METHYLPHENIDATE, methylphenidate hydrochloride 36 mg modified release tablet, 30 (Concerta, METHYLPHENIDATE-TEVA XR, Methylphenidate XR ARX) |
| 2432B | METHYLPHENIDATE, methylphenidate hydrochloride 54 mg modified release tablet, 30 (Concerta, METHYLPHENIDATE-TEVA XR, Methylphenidate XR ARX) |
| 1658G | NAPROXEN, naproxen 125 mg/5 mL oral liquid, 474 mL (Phebra Naproxen Suspension) |
| 14844G | SEMAGLUTIDE, semaglutide 0.68 mg/mL injection, 1 x 3 mL pen device (Ozempic) |
| 14846J | SEMAGLUTIDE, semaglutide 0.68 mg/mL injection, 1 x 3 mL pen device (Ozempic) |
Deletions
Deletion – Item
| 14050L | CARBAMAZEPINE, carbamazepine 200 mg modified release tablet, 200 (Tegretol CR 200) |
| 2426Q | CARBAMAZEPINE, carbamazepine 200 mg modified release tablet, 200 (Tegretol CR 200) |
| 5038E | CARBAMAZEPINE, carbamazepine 200 mg modified release tablet, 200 (Tegretol CR 200) |
| 13918M | CARBAMAZEPINE, carbamazepine 400 mg modified release tablet, 200 (Tegretol CR 400) |
| 2431Y | CARBAMAZEPINE, carbamazepine 400 mg modified release tablet, 200 (Tegretol CR 400) |
| 5037D | CARBAMAZEPINE, carbamazepine 400 mg modified release tablet, 200 (Tegretol CR 400) |
| 1288T | DEXAMETHASONE, dexamethasone 0.1% eye drops, 5 mL (Maxidex) |
| 5565X | DEXAMETHASONE, dexamethasone 0.1% eye drops, 5 mL (Maxidex) |
| 14668B | EZETIMIBE, ezetimibe 10 mg tablet, 90 (Ezetimibe USP (Camber, USA)) |
| 14682R | EZETIMIBE, ezetimibe 10 mg tablet, 90 (Ezetimibe USP (Camber, USA)) |
Deletion – Brand
| 1007B | Aciclovir APOTEX, TY– ACICLOVIR , aciclovir 200 mg tablet, 90 |
| 13358C | Allopurinol APOTEX, GX– ALLOPURINOL , allopurinol 100 mg tablet, 200 |
| 2600W | Allopurinol APOTEX, GX– ALLOPURINOL , allopurinol 100 mg tablet, 200 |
| 13532F | Amlodipine APOTEX, GX– AMLODIPINE , amlodipine 5 mg tablet, 30 |
| 2751T | Amlodipine APOTEX, GX– AMLODIPINE , amlodipine 5 mg tablet, 30 |
| 1887H | Cilamox, AL– AMOXICILLIN , amoxicillin 250 mg/5 mL powder for oral liquid, 100 mL |
| 3393N | Cilamox, AL– AMOXICILLIN , amoxicillin 250 mg/5 mL powder for oral liquid, 100 mL |
| 8844L | Bivalirudin APOTEX, TX– BIVALIRUDIN , bivalirudin 250 mg injection, 1 vial |
| 2460L | Aclor 125, MQ– CEFACLOR , cefaclor 125 mg/5 mL powder for oral liquid, 100 mL |
| 5046N | Aclor 125, MQ– CEFACLOR , cefaclor 125 mg/5 mL powder for oral liquid, 100 mL |
| 2461M | Aclor 250, MQ– CEFACLOR , cefaclor 250 mg/5 mL powder for oral liquid, 75 mL |
| 5047P | Aclor 250, MQ– CEFACLOR , cefaclor 250 mg/5 mL powder for oral liquid, 75 mL |
| 1169M | Karlor CD, MQ– CEFACLOR , cefaclor 375 mg modified release tablet, 10 |
| 5045M | Karlor CD, MQ– CEFACLOR , cefaclor 375 mg modified release tablet, 10 |
| 13385L | Zeklen 10/10 mg, AF– EZETIMIBE + SIMVASTATIN , ezetimibe 10 mg + simvastatin 10 mg tablet, 30 |
| 9483D | Zeklen 10/10 mg, AF– EZETIMIBE + SIMVASTATIN , ezetimibe 10 mg + simvastatin 10 mg tablet, 30 |
| 13442L | Zeklen 10/20 mg, AF– EZETIMIBE + SIMVASTATIN , ezetimibe 10 mg + simvastatin 20 mg tablet, 30 |
| 9484E | Zeklen 10/20 mg, AF– EZETIMIBE + SIMVASTATIN , ezetimibe 10 mg + simvastatin 20 mg tablet, 30 |
| 13535J | Zeklen 10/40 mg, AF– EZETIMIBE + SIMVASTATIN , ezetimibe 10 mg + simvastatin 40 mg tablet, 30 |
| 8881K | Zeklen 10/40 mg, AF– EZETIMIBE + SIMVASTATIN , ezetimibe 10 mg + simvastatin 40 mg tablet, 30 |
| 13595M | Zeklen 10/80 mg, AF– EZETIMIBE + SIMVASTATIN , ezetimibe 10 mg + simvastatin 80 mg tablet, 30 |
| 8882L | Zeklen 10/80 mg, AF– EZETIMIBE + SIMVASTATIN , ezetimibe 10 mg + simvastatin 80 mg tablet, 30 |
| 13377C | Fendex ER, AF– FELODIPINE , felodipine 2.5 mg modified release tablet, 30 |
| 2361G | Fendex ER, AF– FELODIPINE , felodipine 2.5 mg modified release tablet, 30 |
| 13561R | Fendex ER, AF– FELODIPINE , felodipine 5 mg modified release tablet, 30 |
| 2366M | Fendex ER, AF– FELODIPINE , felodipine 5 mg modified release tablet, 30 |
| 13531E | Fendex ER, AF– FELODIPINE , felodipine 10 mg modified release tablet, 30 |
| 2367N | Fendex ER, AF– FELODIPINE , felodipine 10 mg modified release tablet, 30 |
| 14740T | Glyade MR, AF– GLICLAZIDE , gliclazide 30 mg modified release tablet, 100 |
| 8535F | Glyade MR, AF– GLICLAZIDE , gliclazide 30 mg modified release tablet, 100 |
| 13848W | Glimepiride APOTEX, GX– GLIMEPIRIDE , glimepiride 1 mg tablet, 30 |
| 8450R | Glimepiride APOTEX, GX– GLIMEPIRIDE , glimepiride 1 mg tablet, 30 |
| 13870B | Glimepiride APOTEX, GX– GLIMEPIRIDE , glimepiride 2 mg tablet, 30 |
| 8451T | Glimepiride APOTEX, GX– GLIMEPIRIDE , glimepiride 2 mg tablet, 30 |
| 14020X | Glimepiride APOTEX, GX– GLIMEPIRIDE , glimepiride 3 mg tablet, 30 |
| 8533D | Glimepiride APOTEX, GX– GLIMEPIRIDE , glimepiride 3 mg tablet, 30 |
| 14055R | Glimepiride APOTEX, GX– GLIMEPIRIDE , glimepiride 4 mg tablet, 30 |
| 8452W | Glimepiride APOTEX, GX– GLIMEPIRIDE , glimepiride 4 mg tablet, 30 |
| 2546B | Aldiq, AF– IMIQUIMOD , imiquimod 5% cream, 12 x 250 mg sachets |
| 1542E | Ipratrin, AF– IPRATROPIUM , ipratropium bromide 250 microgram/mL inhalation solution, 30 x 1 mL ampoules |
| 8238N | Ipratrin Adult, AF– IPRATROPIUM , ipratropium bromide 500 microgram/mL inhalation solution, 30 x 1 mL ampoules |
| 13940Q | Leflunomide APOTEX, GX– LEFLUNOMIDE , leflunomide 10 mg tablet, 30 |
| 14068K | Leflunomide APOTEX, GX– LEFLUNOMIDE , leflunomide 10 mg tablet, 30 |
| 5449T | Leflunomide APOTEX, GX– LEFLUNOMIDE , leflunomide 10 mg tablet, 30 |
| 8374R | Leflunomide APOTEX, GX– LEFLUNOMIDE , leflunomide 10 mg tablet, 30 |
| 13998R | Leflunomide APOTEX, GX– LEFLUNOMIDE , leflunomide 20 mg tablet, 30 |
| 14069L | Leflunomide APOTEX, GX– LEFLUNOMIDE , leflunomide 20 mg tablet, 30 |
| 5450W | Leflunomide APOTEX, GX– LEFLUNOMIDE , leflunomide 20 mg tablet, 30 |
| 8375T | Leflunomide APOTEX, GX– LEFLUNOMIDE , leflunomide 20 mg tablet, 30 |
| 13411W | Lercanidipine APOTEX, GX– LERCANIDIPINE , lercanidipine hydrochloride 10 mg tablet, 28 |
| 8534E | Lercanidipine APOTEX, GX– LERCANIDIPINE , lercanidipine hydrochloride 10 mg tablet, 28 |
| 13939P | Letrozole APOTEX, GX– LETROZOLE , letrozole 2.5 mg tablet, 30 |
| 8245Y | Letrozole APOTEX, GX– LETROZOLE , letrozole 2.5 mg tablet, 30 |
| 13992K | Kevtam 250, AF– LEVETIRACETAM , levetiracetam 250 mg tablet, 60 |
| 13992K | Levetiracetam Mylan, AL– LEVETIRACETAM , levetiracetam 250 mg tablet, 60 |
| 8654L | Kevtam 250, AF– LEVETIRACETAM , levetiracetam 250 mg tablet, 60 |
| 8654L | Levetiracetam Mylan, AL– LEVETIRACETAM , levetiracetam 250 mg tablet, 60 |
| 14034P | Kevtam 500, AF– LEVETIRACETAM , levetiracetam 500 mg tablet, 60 |
| 8655M | Kevtam 500, AF– LEVETIRACETAM , levetiracetam 500 mg tablet, 60 |
| 13937M | Kevtam 1000, AF– LEVETIRACETAM , levetiracetam 1 g tablet, 60 |
| 13937M | Levetiracetam Mylan, AL– LEVETIRACETAM , levetiracetam 1 g tablet, 60 |
| 8656N | Kevtam 1000, AF– LEVETIRACETAM , levetiracetam 1 g tablet, 60 |
| 8656N | Levetiracetam Mylan, AL– LEVETIRACETAM , levetiracetam 1 g tablet, 60 |
| 10526B | Latuda, SE– LURASIDONE , lurasidone hydrochloride 40 mg tablet, 30 |
| 10529E | Latuda, SE– LURASIDONE , lurasidone hydrochloride 80 mg tablet, 30 |
| 1653B | Morphine MR Mylan, AF– MORPHINE , morphine sulfate pentahydrate 10 mg modified release tablet, 28 |
| 1654C | Morphine MR Mylan, AF– MORPHINE , morphine sulfate pentahydrate 30 mg modified release tablet, 28 |
| 1655D | Morphine MR Mylan, AF– MORPHINE , morphine sulfate pentahydrate 60 mg modified release tablet, 28 |
| 1656E | Morphine MR Mylan, AF– MORPHINE , morphine sulfate pentahydrate 100 mg modified release tablet, 28 |
| 3010K | Nufloxib, AF– NORFLOXACIN , norfloxacin 400 mg tablet, 14 |
| 8170B | Olanzapine APOTEX, GX– OLANZAPINE , olanzapine 2.5 mg tablet, 28 |
| 11681T | Pantoprazole APOTEX, TY– PANTOPRAZOLE , pantoprazole 40 mg enteric tablet, 30 |
| 12277E | Pantoprazole APOTEX, TY– PANTOPRAZOLE , pantoprazole 40 mg enteric tablet, 30 |
| 14330F | Pantoprazole APOTEX, TY– PANTOPRAZOLE , pantoprazole 40 mg enteric tablet, 30 |
| 14362X | Pantoprazole APOTEX, TY– PANTOPRAZOLE , pantoprazole 40 mg enteric tablet, 30 |
| 14394N | Pantoprazole APOTEX, TY– PANTOPRAZOLE , pantoprazole 40 mg enteric tablet, 30 |
| 8007K | Pantoprazole APOTEX, TY– PANTOPRAZOLE , pantoprazole 40 mg enteric tablet, 30 |
| 8008L | Pantoprazole APOTEX, TY– PANTOPRAZOLE , pantoprazole 40 mg enteric tablet, 30 |
| 13588E | Rosuvastatin APOTEX, GX– ROSUVASTATIN , rosuvastatin 20 mg tablet, 30 |
| 2574L | Rosuvastatin APOTEX, GX– ROSUVASTATIN , rosuvastatin 20 mg tablet, 30 |
| 13589F | Rosuvastatin APOTEX, GX– ROSUVASTATIN , rosuvastatin 40 mg tablet, 30 |
| 2594M | Rosuvastatin APOTEX, GX– ROSUVASTATIN , rosuvastatin 40 mg tablet, 30 |
| 11856B | Sevelamer Apotex, TX– SEVELAMER , sevelamer carbonate 800 mg tablet, 180 |
| 14027G | Sevelamer Apotex, TX– SEVELAMER , sevelamer carbonate 800 mg tablet, 180 |
| 8144P | IMIGRAN MIGRAINE, AS– SUMATRIPTAN , sumatriptan 50 mg tablet, 2 |
| 8144P | Imigran, LN– SUMATRIPTAN , sumatriptan 50 mg tablet, 2 |
Deletion – Equivalence Indicator
| 8844L | BIVALIRUDIN ARX, XT– BIVALIRUDIN , bivalirudin 250 mg injection, 1 vial |
| 14671E | Tegretol CR 200, NV– CARBAMAZEPINE , carbamazepine 200 mg modified release tablet, 100 |
| 14673G | Tegretol CR 200, NV– CARBAMAZEPINE , carbamazepine 200 mg modified release tablet, 100 |
| 14681Q | Tegretol CR 200, NV– CARBAMAZEPINE , carbamazepine 200 mg modified release tablet, 100 |
| 14662Q | Tegretol CR 400, NV– CARBAMAZEPINE , carbamazepine 400 mg modified release tablet, 100 |
| 14666X | Tegretol CR 400, NV– CARBAMAZEPINE , carbamazepine 400 mg modified release tablet, 100 |
| 14680P | Tegretol CR 400, NV– CARBAMAZEPINE , carbamazepine 400 mg modified release tablet, 100 |
| 1542E | Atrovent, BY– IPRATROPIUM , ipratropium bromide 250 microgram/mL inhalation solution, 30 x 1 mL ampoules |
| 8238N | Atrovent Adult, BY– IPRATROPIUM , ipratropium bromide 500 microgram/mL inhalation solution, 30 x 1 mL ampoules |
Deletion – Note
| 13897K | ALOGLIPTIN, alogliptin 6.25 mg tablet, 28 (Nesina) |
| 2944Y | ALOGLIPTIN, alogliptin 6.25 mg tablet, 28 (Nesina) |
| 13977P | ALOGLIPTIN, alogliptin 12.5 mg tablet, 28 (Nesina) |
| 2933J | ALOGLIPTIN, alogliptin 12.5 mg tablet, 28 (Nesina) |
| 13953J | ALOGLIPTIN, alogliptin 25 mg tablet, 28 (Nesina) |
| 2986E | ALOGLIPTIN, alogliptin 25 mg tablet, 28 (Nesina) |
| 10035E | ALOGLIPTIN + METFORMIN, alogliptin 12.5 mg + metformin hydrochloride 1 g tablet, 56 (Nesina Met 12.5/1000) |
| 13989G | ALOGLIPTIN + METFORMIN, alogliptin 12.5 mg + metformin hydrochloride 1 g tablet, 56 (Nesina Met 12.5/1000) |
| 10033C | ALOGLIPTIN + METFORMIN, alogliptin 12.5 mg + metformin hydrochloride 500 mg tablet, 56 (Nesina Met 12.5/500) |
| 14062D | ALOGLIPTIN + METFORMIN, alogliptin 12.5 mg + metformin hydrochloride 500 mg tablet, 56 (Nesina Met 12.5/500) |
| 10032B | ALOGLIPTIN + METFORMIN, alogliptin 12.5 mg + metformin hydrochloride 850 mg tablet, 56 (Nesina Met 12.5/850) |
| 14061C | ALOGLIPTIN + METFORMIN, alogliptin 12.5 mg + metformin hydrochloride 850 mg tablet, 56 (Nesina Met 12.5/850) |
| 14671E | CARBAMAZEPINE, carbamazepine 200 mg modified release tablet, 100 (Tegretol CR 200) |
| 14673G | CARBAMAZEPINE, carbamazepine 200 mg modified release tablet, 100 (Tegretol CR 200) |
| 14681Q | CARBAMAZEPINE, carbamazepine 200 mg modified release tablet, 100 (Tegretol CR 200) |
| 14662Q | CARBAMAZEPINE, carbamazepine 400 mg modified release tablet, 100 (Tegretol CR 400) |
| 14666X | CARBAMAZEPINE, carbamazepine 400 mg modified release tablet, 100 (Tegretol CR 400) |
| 14680P | CARBAMAZEPINE, carbamazepine 400 mg modified release tablet, 100 (Tegretol CR 400) |
| 13440J | EZETIMIBE, ezetimibe 10 mg tablet, 30 (APO-Ezetimibe, ARX-EZETIMIBE, BTC Ezetimibe, EZEMICHOL, EZETIMIBE-WGR, Ezetimibe GH, Ezetimibe Sandoz, Ezetrol, Pharmacor Ezetimibe 10, Zient 10mg) |
| 8757X | EZETIMIBE, ezetimibe 10 mg tablet, 30 (APO-Ezetimibe, ARX-EZETIMIBE, BTC Ezetimibe, EZEMICHOL, EZETIMIBE-WGR, Ezetimibe GH, Ezetimibe Sandoz, Ezetrol, Pharmacor Ezetimibe 10, Zient 10mg) |
Alterations
Alteration – Item Description
| From | |
| 14378R | BECLOMETHASONE, beclometasone dipropionate 50 microgram/actuation breath activated inhalation, 200 actuations (Qvar 50 Autohaler) |
| To | |
| 14378R | BECLOMETASONE, beclometasone dipropionate 50 microgram/actuation breath activated inhalation, 200 actuations (Qvar 50 Autohaler) |
| From | |
| 14540G | BECLOMETHASONE, beclometasone dipropionate 50 microgram/actuation inhalation, 200 actuations (Qvar 50) |
| To | |
| 14540G | BECLOMETASONE, beclometasone dipropionate 50 microgram/actuation inhalation, 200 actuations (Qvar 50) |
| From | |
| 8406K | BECLOMETHASONE, beclometasone dipropionate 50 microgram/actuation inhalation, 200 actuations (Qvar 50) |
| To | |
| 8406K | BECLOMETASONE, beclometasone dipropionate 50 microgram/actuation inhalation, 200 actuations (Qvar 50) |
| From | |
| 8408M | BECLOMETHASONE, beclometasone dipropionate 50 microgram/actuation breath activated inhalation, 200 actuations (Qvar 50 Autohaler) |
| To | |
| 8408M | BECLOMETASONE, beclometasone dipropionate 50 microgram/actuation breath activated inhalation, 200 actuations (Qvar 50 Autohaler) |
| From | |
| 14514X | BECLOMETHASONE, beclometasone dipropionate 100 microgram/actuation breath activated inhalation, 200 actuations (Qvar 100 Autohaler) |
| To | |
| 14514X | BECLOMETASONE, beclometasone dipropionate 100 microgram/actuation breath activated inhalation, 200 actuations (Qvar 100 Autohaler) |
| From | |
| 14541H | BECLOMETHASONE, beclometasone dipropionate 100 microgram/actuation inhalation, 200 actuations (Qvar 100) |
| To | |
| 14541H | BECLOMETASONE, beclometasone dipropionate 100 microgram/actuation inhalation, 200 actuations (Qvar 100) |
| From | |
| 8407L | BECLOMETHASONE, beclometasone dipropionate 100 microgram/actuation inhalation, 200 actuations (Qvar 100) |
| To | |
| 8407L | BECLOMETASONE, beclometasone dipropionate 100 microgram/actuation inhalation, 200 actuations (Qvar 100) |
| From | |
| 8409N | BECLOMETHASONE, beclometasone dipropionate 100 microgram/actuation breath activated inhalation, 200 actuations (Qvar 100 Autohaler) |
| To | |
| 8409N | BECLOMETASONE, beclometasone dipropionate 100 microgram/actuation breath activated inhalation, 200 actuations (Qvar 100 Autohaler) |
Alteration – Note
| 11207W | ETANERCEPT, etanercept 25 mg injection [4 vials] (&) inert substance diluent [4 x 1 mL syringes], 1 pack (Enbrel) |
| 11223Q | ETANERCEPT, etanercept 25 mg injection [4 vials] (&) inert substance diluent [4 x 1 mL syringes], 1 pack (Enbrel) |
| 3445H | ETANERCEPT, etanercept 25 mg injection [4 vials] (&) inert substance diluent [4 x 1 mL syringes], 1 pack (Enbrel) |
| 3448L | ETANERCEPT, etanercept 25 mg injection [4 vials] (&) inert substance diluent [4 x 1 mL syringes], 1 pack (Enbrel) |
| 8637N | ETANERCEPT, etanercept 25 mg injection [4 vials] (&) inert substance diluent [4 x 1 mL syringes], 1 pack (Enbrel) |
| 8778B | ETANERCEPT, etanercept 25 mg injection [4 vials] (&) inert substance diluent [4 x 1 mL syringes], 1 pack (Enbrel) |
| 9035M | ETANERCEPT, etanercept 25 mg injection [4 vials] (&) inert substance diluent [4 x 1 mL syringes], 1 pack (Enbrel) |
| 9036N | ETANERCEPT, etanercept 25 mg injection [4 vials] (&) inert substance diluent [4 x 1 mL syringes], 1 pack (Enbrel) |
| 9037P | ETANERCEPT, etanercept 25 mg injection [4 vials] (&) inert substance diluent [4 x 1 mL syringes], 1 pack (Enbrel) |
| 9429G | ETANERCEPT, etanercept 25 mg injection [4 vials] (&) inert substance diluent [4 x 1 mL syringes], 1 pack (Enbrel) |
| 11198J | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices (Brenzys, Enbrel, Nepexto) |
| 11202N | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices (Brenzys, Nepexto) |
| 11221N | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices (Brenzys, Nepexto) |
| 11222P | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices (Brenzys, Enbrel, Nepexto) |
| 13687J | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices (Brenzys, Nepexto) |
| 13774Y | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices (Brenzys, Nepexto) |
| 3447K | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices (Enbrel, Nepexto) |
| 3450N | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices (Enbrel, Nepexto) |
| 9455P | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices (Brenzys, Enbrel, Nepexto) |
| 9457R | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices (Brenzys, Enbrel, Nepexto) |
| 9458T | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices (Brenzys, Enbrel, Nepexto) |
| 9459W | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices (Brenzys, Enbrel, Nepexto) |
| 9461Y | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices (Brenzys, Enbrel, Nepexto) |
| 9462B | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices (Brenzys, Enbrel, Nepexto) |
| 11208X | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes (Brenzys, Enbrel) |
| 11216H | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes (Brenzys) |
| 11224R | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes (Brenzys, Enbrel) |
| 11225T | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes (Brenzys) |
| 13698Y | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes (Brenzys) |
| 13751R | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes (Brenzys) |
| 3446J | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes (Enbrel) |
| 3449M | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes (Enbrel) |
| 9085E | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes (Brenzys, Enbrel) |
| 9087G | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes (Brenzys, Enbrel) |
| 9088H | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes (Brenzys, Enbrel) |
| 9089J | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes (Brenzys, Enbrel) |
| 9091L | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes (Brenzys, Enbrel) |
| 9431J | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes (Brenzys, Enbrel) |
| 14737P | FARICIMAB, faricimab 6 mg/0.05 mL intraocular injection, 0.05 mL vial (Vabysmo) |
| 14738Q | FARICIMAB, faricimab 6 mg/0.05 mL intraocular injection, 0.05 mL vial (Vabysmo) |
Alteration – Restriction
| 14116Y | ABEMACICLIB, abemaciclib 50 mg tablet, 56 (Verzenio) |
| 14105J | ABEMACICLIB, abemaciclib 100 mg tablet, 56 (Verzenio) |
| 14134X | ABEMACICLIB, abemaciclib 150 mg tablet, 56 (Verzenio) |
| 11204Q | ETANERCEPT, etanercept 25 mg injection [4 vials] (&) inert substance diluent [4 x 1 mL syringes], 1 pack (Enbrel) |
| 11207W | ETANERCEPT, etanercept 25 mg injection [4 vials] (&) inert substance diluent [4 x 1 mL syringes], 1 pack (Enbrel) |
| 11223Q | ETANERCEPT, etanercept 25 mg injection [4 vials] (&) inert substance diluent [4 x 1 mL syringes], 1 pack (Enbrel) |
| 3445H | ETANERCEPT, etanercept 25 mg injection [4 vials] (&) inert substance diluent [4 x 1 mL syringes], 1 pack (Enbrel) |
| 3448L | ETANERCEPT, etanercept 25 mg injection [4 vials] (&) inert substance diluent [4 x 1 mL syringes], 1 pack (Enbrel) |
| 8637N | ETANERCEPT, etanercept 25 mg injection [4 vials] (&) inert substance diluent [4 x 1 mL syringes], 1 pack (Enbrel) |
| 8638P | ETANERCEPT, etanercept 25 mg injection [4 vials] (&) inert substance diluent [4 x 1 mL syringes], 1 pack (Enbrel) |
| 8778B | ETANERCEPT, etanercept 25 mg injection [4 vials] (&) inert substance diluent [4 x 1 mL syringes], 1 pack (Enbrel) |
| 8779C | ETANERCEPT, etanercept 25 mg injection [4 vials] (&) inert substance diluent [4 x 1 mL syringes], 1 pack (Enbrel) |
| 9035M | ETANERCEPT, etanercept 25 mg injection [4 vials] (&) inert substance diluent [4 x 1 mL syringes], 1 pack (Enbrel) |
| 9036N | ETANERCEPT, etanercept 25 mg injection [4 vials] (&) inert substance diluent [4 x 1 mL syringes], 1 pack (Enbrel) |
| 9037P | ETANERCEPT, etanercept 25 mg injection [4 vials] (&) inert substance diluent [4 x 1 mL syringes], 1 pack (Enbrel) |
| 9429G | ETANERCEPT, etanercept 25 mg injection [4 vials] (&) inert substance diluent [4 x 1 mL syringes], 1 pack (Enbrel) |
| 11198J | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices (Brenzys, Enbrel, Nepexto) |
| 11201M | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices (Brenzys, Enbrel, Nepexto) |
| 11202N | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices (Brenzys, Nepexto) |
| 11221N | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices (Brenzys, Nepexto) |
| 11222P | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices (Brenzys, Enbrel, Nepexto) |
| 3447K | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices (Enbrel, Nepexto) |
| 3450N | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices (Enbrel, Nepexto) |
| 9455P | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices (Brenzys, Enbrel, Nepexto) |
| 9456Q | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices (Brenzys, Enbrel, Nepexto) |
| 9457R | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices (Brenzys, Enbrel, Nepexto) |
| 9458T | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices (Brenzys, Enbrel, Nepexto) |
| 9459W | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices (Brenzys, Enbrel, Nepexto) |
| 9460X | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices (Brenzys, Enbrel, Nepexto) |
| 9461Y | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices (Brenzys, Enbrel, Nepexto) |
| 9462B | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices (Brenzys, Enbrel, Nepexto) |
| 11196G | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes (Brenzys, Enbrel) |
| 11208X | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes (Brenzys, Enbrel) |
| 11216H | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes (Brenzys) |
| 11224R | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes (Brenzys, Enbrel) |
| 11225T | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes (Brenzys) |
| 3446J | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes (Enbrel) |
| 3449M | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes (Enbrel) |
| 9085E | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes (Brenzys, Enbrel) |
| 9086F | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes (Brenzys, Enbrel) |
| 9087G | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes (Brenzys, Enbrel) |
| 9088H | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes (Brenzys, Enbrel) |
| 9089J | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes (Brenzys, Enbrel) |
| 9090K | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes (Brenzys, Enbrel) |
| 9091L | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes (Brenzys, Enbrel) |
| 9431J | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes (Brenzys, Enbrel) |
| 14181J | OLAPARIB, olaparib 100 mg tablet, 56 (Lynparza) |
| 14216F | OLAPARIB, olaparib 100 mg tablet, 56 (Lynparza) |
| 14208T | OLAPARIB, olaparib 150 mg tablet, 56 (Lynparza) |
| 14215E | OLAPARIB, olaparib 150 mg tablet, 56 (Lynparza) |
Alteration – Manufacturer Code
| From | To | ||
| 13032X | Ruzurgi– AMIFAMPRIDINE , amifampridine 10 mg tablet, 100 | OJ | LD |
| 12652X | Reagila– CARIPRAZINE , cariprazine 1.5 mg capsule, 30 | CS | IX |
| 12619E | Reagila– CARIPRAZINE , cariprazine 3 mg capsule, 30 | CS | IX |
| 12653Y | Reagila– CARIPRAZINE , cariprazine 4.5 mg capsule, 30 | CS | IX |
| 12622H | Reagila– CARIPRAZINE , cariprazine 6 mg capsule, 30 | CS | IX |
| 11123K | Valtresto– SACUBITRIL + VALSARTAN , sacubitril 24.3 mg + valsartan 25.7 mg tablet, 56 | RM | TX |
| 13570F | Valtresto– SACUBITRIL + VALSARTAN , sacubitril 24.3 mg + valsartan 25.7 mg tablet, 56 | RM | TX |
| 11131W | Valtresto– SACUBITRIL + VALSARTAN , sacubitril 48.6 mg + valsartan 51.4 mg tablet, 56 | RM | TX |
| 13511D | Valtresto– SACUBITRIL + VALSARTAN , sacubitril 48.6 mg + valsartan 51.4 mg tablet, 56 | RM | TX |
| 11122J | Valtresto– SACUBITRIL + VALSARTAN , sacubitril 97.2 mg + valsartan 102.8 mg tablet, 56 | RM | TX |
| 13445P | Valtresto– SACUBITRIL + VALSARTAN , sacubitril 97.2 mg + valsartan 102.8 mg tablet, 56 | RM | TX |
Supply Only
Supply Only – Period Commencing
| 14335L | GLYCERYL TRINITRATE, glyceryl trinitrate 15 mg/24 hours patch, 30 (Minitran 15) |
| 8119H | GLYCERYL TRINITRATE, glyceryl trinitrate 15 mg/24 hours patch, 30 (Minitran 15) |
Supply Only – Period Ending
| 5519L | HYPROMELLOSE + CARBOMER-980, hypromellose 0.3% + carbomer-980 0.2% eye gel, 10 g (Genteal gel, HPMC PAA) |
| 8564R | HYPROMELLOSE + CARBOMER-980, hypromellose 0.3% + carbomer-980 0.2% eye gel, 10 g (Genteal gel, HPMC PAA) |
| 9215B | HYPROMELLOSE + CARBOMER-980, hypromellose 0.3% + carbomer-980 0.2% eye gel, 10 g (Genteal gel, HPMC PAA) |
Supply Only – Addition Equivalence Indicator
This change will impact items which are currently available for supply only
| 12080T | Ozempic, NO– SEMAGLUTIDE , semaglutide 1.34 mg/mL injection, 1 x 1.5 mL pen device |
| 14149Q | Ozempic, NO– SEMAGLUTIDE , semaglutide 1.34 mg/mL injection, 1 x 1.5 mL pen device |
Supply Only – Addition Note
This change will impact items which are currently available for supply only
| 12080T | SEMAGLUTIDE, semaglutide 1.34 mg/mL injection, 1 x 1.5 mL pen device (Ozempic) |
| 14149Q | SEMAGLUTIDE, semaglutide 1.34 mg/mL injection, 1 x 1.5 mL pen device (Ozempic) |
Advance Notices
1 August 2025
Deletion – Brand
| 1052J | Aciclovir APOTEX, TY– ACICLOVIR , aciclovir 800 mg tablet, 35 |
| 11329G | Giotrif, BY– AFATINIB , afatinib 50 mg tablet, 28 |
| 11342Y | Giotrif, BY– AFATINIB , afatinib 50 mg tablet, 28 |
| 9438R | GA gel, VF– AMINO ACID FORMULA WITH VITAMINS AND MINERALS WITHOUT LYSINE AND LOW IN TRYPTOPHAN , amino acid formula with vitamins and minerals without lysine and low in tryptophan powder for oral liquid, 30 x 24 g sachets |
| 14425F | Betoptic, NV– BETAXOLOL , betaxolol 0.5% eye drops, 5 mL |
| 2825Q | Betoptic, NV– BETAXOLOL , betaxolol 0.5% eye drops, 5 mL |
| 5544T | Betoptic, NV– BETAXOLOL , betaxolol 0.5% eye drops, 5 mL |
| 8878G | Durogesic 12, JC– FENTANYL , fentanyl 12 microgram/hour patch, 5 |
| 8891Y | Durogesic 25, JC– FENTANYL , fentanyl 25 microgram/hour patch, 5 |
| 8892B | Durogesic 50, JC– FENTANYL , fentanyl 50 microgram/hour patch, 5 |
| 8893C | Durogesic 75, JC– FENTANYL , fentanyl 75 microgram/hour patch, 5 |
| 8894D | Durogesic 100, JC– FENTANYL , fentanyl 100 microgram/hour patch, 5 |
| 8729K | Granisetron-AFT, AE– GRANISETRON , granisetron 3 mg/3 mL injection, 3 mL ampoule |
| 8730L | Granisetron-AFT, AE– GRANISETRON , granisetron 3 mg/3 mL injection, 3 mL ampoule |
| 14526M | Montelukast APOTEX, GX– MONTELUKAST , montelukast 4 mg chewable tablet, 28 |
| 14526M | Montelukast Mylan, AF– MONTELUKAST , montelukast 4 mg chewable tablet, 28 |
| 8627C | Montelukast APOTEX, GX– MONTELUKAST , montelukast 4 mg chewable tablet, 28 |
| 8627C | Montelukast Mylan, AF– MONTELUKAST , montelukast 4 mg chewable tablet, 28 |
| 14194C | RA-Morph (NZ), WZ– MORPHINE , morphine hydrochloride trihydrate 10 mg/mL oral liquid, 200 mL |
| 14204N | RA-Morph (NZ), WZ– MORPHINE , morphine hydrochloride trihydrate 10 mg/mL oral liquid, 200 mL |
| 10005N | Olmekar HCT 20/5/12.5, RF– OLMESARTAN + AMLODIPINE + HYDROCHLOROTHIAZIDE , olmesartan medoxomil 20 mg + amlodipine 5 mg + hydrochlorothiazide 12.5 mg tablet, 30 |
| 13481M | Olmekar HCT 20/5/12.5, RF– OLMESARTAN + AMLODIPINE + HYDROCHLOROTHIAZIDE , olmesartan medoxomil 20 mg + amlodipine 5 mg + hydrochlorothiazide 12.5 mg tablet, 30 |
| 13482N | Olmekar HCT 40/10/12.5, RF– OLMESARTAN + AMLODIPINE + HYDROCHLOROTHIAZIDE , olmesartan medoxomil 40 mg + amlodipine 10 mg + hydrochlorothiazide 12.5 mg tablet, 30 |
| 13512E | Olmekar HCT 40/5/25, RF– OLMESARTAN + AMLODIPINE + HYDROCHLOROTHIAZIDE , olmesartan medoxomil 40 mg + amlodipine 5 mg + hydrochlorothiazide 25 mg tablet, 30 |
| 13513F | Olmekar HCT 40/5/12.5, RF– OLMESARTAN + AMLODIPINE + HYDROCHLOROTHIAZIDE , olmesartan medoxomil 40 mg + amlodipine 5 mg + hydrochlorothiazide 12.5 mg tablet, 30 |
| 14002Y | Olmekar HCT 40/10/25, RF– OLMESARTAN + AMLODIPINE + HYDROCHLOROTHIAZIDE , olmesartan medoxomil 40 mg + amlodipine 10 mg + hydrochlorothiazide 25 mg tablet, 30 |
| 2836G | Olmekar HCT 40/10/12.5, RF– OLMESARTAN + AMLODIPINE + HYDROCHLOROTHIAZIDE , olmesartan medoxomil 40 mg + amlodipine 10 mg + hydrochlorothiazide 12.5 mg tablet, 30 |
| 2864R | Olmekar HCT 40/5/25, RF– OLMESARTAN + AMLODIPINE + HYDROCHLOROTHIAZIDE , olmesartan medoxomil 40 mg + amlodipine 5 mg + hydrochlorothiazide 25 mg tablet, 30 |
| 2880N | Olmekar HCT 40/5/12.5, RF– OLMESARTAN + AMLODIPINE + HYDROCHLOROTHIAZIDE , olmesartan medoxomil 40 mg + amlodipine 5 mg + hydrochlorothiazide 12.5 mg tablet, 30 |
| 2953K | Olmekar HCT 40/10/25, RF– OLMESARTAN + AMLODIPINE + HYDROCHLOROTHIAZIDE , olmesartan medoxomil 40 mg + amlodipine 10 mg + hydrochlorothiazide 25 mg tablet, 30 |
| 14367E | Noumed Paroxetine, VO– PAROXETINE , paroxetine 20 mg tablet, 30 |
| 2242B | Noumed Paroxetine, VO– PAROXETINE , paroxetine 20 mg tablet, 30 |
| 8589C | Accuretic 10/12.5mg, PF– QUINAPRIL + HYDROCHLOROTHIAZIDE , quinapril 10 mg + hydrochlorothiazide 12.5 mg tablet, 30 |
| 8590D | Accuretic 20/12.5mg, PF– QUINAPRIL + HYDROCHLOROTHIAZIDE , quinapril 20 mg + hydrochlorothiazide 12.5 mg tablet, 30 |
| 8527T | Metalyse, BY– TENECTEPLASE , tenecteplase 50 mg injection [1 vial] (&) inert substance diluent [10 mL syringe], 1 pack |
| 14636H | Emtricitabine and Tenofovir Disoproxil Fumarate 200 mg/300 mg Tablets (Laurus Labs, USA), KQ– TENOFOVIR DISOPROXIL + EMTRICITABINE , tenofovir disoproxil fumarate 300 mg + emtricitabine 200 mg tablet, 30 |
| 10622C | Hymenoptera Yellow Jacket Venom, DE– YELLOW JACKET VENOM , yellow jacket venom 550 microgram injection [1 vial] (&) inert substance diluent [9 mL vial], 1 pack |
1 September 2025
Deletion – Brand
| 1555W | Aciclovir APOTEX, TY– ACICLOVIR , aciclovir 200 mg tablet, 50 |
| 13575L | Allopurinol APOTEX, GX– ALLOPURINOL , allopurinol 300 mg tablet, 60 |
| 2604C | Allopurinol APOTEX, GX– ALLOPURINOL , allopurinol 300 mg tablet, 60 |
| 5296R | Riamet 20mg/120mg Dispersible, NV– ARTEMETHER + LUMEFANTRINE , artemether 20 mg + lumefantrine 120 mg dispersible tablet, 18 |
| 5265D | Denpax, AF– FENTANYL , fentanyl 12 microgram/hour patch, 5 |
| 5277R | Denpax, AF– FENTANYL , fentanyl 25 microgram/hour patch, 5 |
| 5278T | Denpax, AF– FENTANYL , fentanyl 50 microgram/hour patch, 5 |
| 5279W | Denpax, AF– FENTANYL , fentanyl 75 microgram/hour patch, 5 |
| 5280X | Denpax, AF– FENTANYL , fentanyl 100 microgram/hour patch, 5 |
| 10915L | Imatinib-APOTEX, TX– IMATINIB , imatinib 100 mg capsule, 60 |
| 10918P | Imatinib-APOTEX, TX– IMATINIB , imatinib 100 mg capsule, 60 |
| 10920R | Imatinib-APOTEX, TX– IMATINIB , imatinib 100 mg capsule, 60 |
| 10924Y | Imatinib-APOTEX, TX– IMATINIB , imatinib 100 mg capsule, 60 |
| 10940T | Imatinib-APOTEX, TX– IMATINIB , imatinib 100 mg capsule, 60 |
| 10941W | Imatinib-APOTEX, TX– IMATINIB , imatinib 100 mg capsule, 60 |
| 10942X | Imatinib-APOTEX, TX– IMATINIB , imatinib 100 mg capsule, 60 |
| 11757T | Imatinib-APOTEX, TX– IMATINIB , imatinib 100 mg capsule, 60 |
| 11770L | Imatinib-APOTEX, TX– IMATINIB , imatinib 100 mg capsule, 60 |
| 11776T | Imatinib-APOTEX, TX– IMATINIB , imatinib 100 mg capsule, 60 |
| 11777W | Imatinib-APOTEX, TX– IMATINIB , imatinib 100 mg capsule, 60 |
| 11782D | Imatinib-APOTEX, TX– IMATINIB , imatinib 100 mg capsule, 60 |
| 11783E | Imatinib-APOTEX, TX– IMATINIB , imatinib 100 mg capsule, 60 |
| 11875B | Imatinib-APOTEX, TX– IMATINIB , imatinib 100 mg capsule, 60 |
| 12709X | Imatinib-APOTEX, TX– IMATINIB , imatinib 100 mg capsule, 60 |
| 12710Y | Imatinib-APOTEX, TX– IMATINIB , imatinib 100 mg capsule, 60 |
| 12722N | Imatinib-APOTEX, TX– IMATINIB , imatinib 100 mg capsule, 60 |
| 12759M | Imatinib-APOTEX, TX– IMATINIB , imatinib 100 mg capsule, 60 |
| 14553Y | Montelukast APOTEX, GX– MONTELUKAST , montelukast 5 mg chewable tablet, 28 |
| 14553Y | Montelukast Mylan, AF– MONTELUKAST , montelukast 5 mg chewable tablet, 28 |
| 8628D | Montelukast APOTEX, GX– MONTELUKAST , montelukast 5 mg chewable tablet, 28 |
| 8628D | Montelukast Mylan, AF– MONTELUKAST , montelukast 5 mg chewable tablet, 28 |
| 13449W | Olmesartan/Amlodipine 20/5 APOTEX, TX– OLMESARTAN + AMLODIPINE , olmesartan medoxomil 20 mg + amlodipine 5 mg tablet, 30 |
| 5292M | Olmesartan/Amlodipine 20/5 APOTEX, TX– OLMESARTAN + AMLODIPINE , olmesartan medoxomil 20 mg + amlodipine 5 mg tablet, 30 |
| 13898L | APOTEX-Pioglitazone, TX– PIOGLITAZONE , pioglitazone 15 mg tablet, 28 |
| 8694N | APOTEX-Pioglitazone, TX– PIOGLITAZONE , pioglitazone 15 mg tablet, 28 |
| 13406N | Rosuvastatin APOTEX, GX– ROSUVASTATIN , rosuvastatin 5 mg tablet, 30 |
| 2606E | Rosuvastatin APOTEX, GX– ROSUVASTATIN , rosuvastatin 5 mg tablet, 30 |
1 October 2025
Deletion – Brand
| 13419G | NOUMED BISOPROLOL, VO– BISOPROLOL , bisoprolol fumarate 2.5 mg tablet, 28 |
| 13443M | NOUMED BISOPROLOL, VO– BISOPROLOL , bisoprolol fumarate 5 mg tablet, 28 |
| 13444N | NOUMED BISOPROLOL, VO– BISOPROLOL , bisoprolol fumarate 10 mg tablet, 28 |
| 8604W | NOUMED BISOPROLOL, VO– BISOPROLOL , bisoprolol fumarate 2.5 mg tablet, 28 |
| 8605X | NOUMED BISOPROLOL, VO– BISOPROLOL , bisoprolol fumarate 5 mg tablet, 28 |
| 8606Y | NOUMED BISOPROLOL, VO– BISOPROLOL , bisoprolol fumarate 10 mg tablet, 28 |
| 1475P | Fluconazole APOTEX, GX– FLUCONAZOLE , fluconazole 200 mg capsule, 28 |
| 14526M | Montelukast APOTEX, GX– MONTELUKAST , montelukast 4 mg chewable tablet, 28 |
| 14526M | Montelukast Mylan, AF– MONTELUKAST , montelukast 4 mg chewable tablet, 28 |
| 14553Y | Montelukast APOTEX, GX– MONTELUKAST , montelukast 5 mg chewable tablet, 28 |
| 14553Y | Montelukast Mylan, AF– MONTELUKAST , montelukast 5 mg chewable tablet, 28 |
| 8627C | Montelukast APOTEX, GX– MONTELUKAST , montelukast 4 mg chewable tablet, 28 |
| 8627C | Montelukast Mylan, AF– MONTELUKAST , montelukast 4 mg chewable tablet, 28 |
| 8628D | Montelukast APOTEX, GX– MONTELUKAST , montelukast 5 mg chewable tablet, 28 |
| 8628D | Montelukast Mylan, AF– MONTELUKAST , montelukast 5 mg chewable tablet, 28 |
| 8185T | Olanzapine APOTEX, GX– OLANZAPINE , olanzapine 5 mg tablet, 28 |
| 13964Y | Olmesartan/Amlodipine 40/5 APOTEX, TX– OLMESARTAN + AMLODIPINE , olmesartan medoxomil 40 mg + amlodipine 5 mg tablet, 30 |
| 5293N | Olmesartan/Amlodipine 40/5 APOTEX, TX– OLMESARTAN + AMLODIPINE , olmesartan medoxomil 40 mg + amlodipine 5 mg tablet, 30 |
| 5470X | Ondansetron Mylan ODT, AF– ONDANSETRON , ondansetron 4 mg orally disintegrating tablet, 4 |
| 5472B | Ondansetron Mylan ODT, AF– ONDANSETRON , ondansetron 4 mg orally disintegrating tablet, 10 |
| 13997Q | Tamosin, OX– TAMOXIFEN , tamoxifen 20 mg tablet, 60 |
| 2110C | Tamosin, OX– TAMOXIFEN , tamoxifen 20 mg tablet, 60 |
Palliative Care
Additions
Addition – Item
| 14867L | NAPROXEN, naproxen 125 mg/5 mL oral liquid, 474 mL (Pediapharm Naproxen Suspension 25 mg/mL (Medexus Pharma, Canada)) |
Addition – Equivalence Indicator
| 5397C | Phebra Naproxen Suspension, FF– NAPROXEN , naproxen 125 mg/5 mL oral liquid, 474 mL |
Addition – Note
| 5397C | NAPROXEN, naproxen 125 mg/5 mL oral liquid, 474 mL (Phebra Naproxen Suspension) |
Deletions
Deletion – Brand
| 12547J | Morphine MR Mylan, AF– MORPHINE , morphine sulfate pentahydrate 10 mg modified release tablet, 28 |
| 12500X | Morphine MR Mylan, AF– MORPHINE , morphine sulfate pentahydrate 30 mg modified release tablet, 28 |
| 12544F | Morphine MR Mylan, AF– MORPHINE , morphine sulfate pentahydrate 60 mg modified release tablet, 28 |
| 12483B | Morphine MR Mylan, AF– MORPHINE , morphine sulfate pentahydrate 100 mg modified release tablet, 28 |
Advance Notices
1 August 2025
Deletion – Brand
| 12474M | Durogesic 75, JC– FENTANYL , fentanyl 75 microgram/hour patch, 5 |
| 12477Q | Durogesic 50, JC– FENTANYL , fentanyl 50 microgram/hour patch, 5 |
| 12504D | Durogesic 25, JC– FENTANYL , fentanyl 25 microgram/hour patch, 5 |
| 12509J | Durogesic 100, JC– FENTANYL , fentanyl 100 microgram/hour patch, 5 |
| 12541C | Durogesic 12, JC– FENTANYL , fentanyl 12 microgram/hour patch, 5 |
| 14187Q | RA-Morph (NZ), WZ– MORPHINE , morphine hydrochloride trihydrate 10 mg/mL oral liquid, 200 mL |
1 September 2025
Deletion – Brand
| 12491K | Denpax, AF– FENTANYL , fentanyl 12 microgram/hour patch, 5 |
| 12516R | Denpax, AF– FENTANYL , fentanyl 25 microgram/hour patch, 5 |
| 12526G | Denpax, AF– FENTANYL , fentanyl 75 microgram/hour patch, 5 |
| 12533P | Denpax, AF– FENTANYL , fentanyl 100 microgram/hour patch, 5 |
| 12546H | Denpax, AF– FENTANYL , fentanyl 50 microgram/hour patch, 5 |
Highly Specialised Drugs Program (Private Hospital)
Additions
Addition – Item
| 14865J | MARIBAVIR, maribavir 200 mg tablet, 28 (Livtencity) |
Addition – Brand
| 13326J | Nepexto, GQ– ETANERCEPT , etanercept 50 mg/mL injection, 4 x 1 mL pen devices |
| 9641K | Nepexto, GQ– ETANERCEPT , etanercept 50 mg/mL injection, 4 x 1 mL pen devices |
Addition – Note
| 6367D | ETANERCEPT, etanercept 25 mg injection [4 vials] (&) inert substance diluent [4 x 1 mL syringes], 1 pack (Enbrel) |
Addition – Caution
| 13326J | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices (Enbrel, Nepexto) |
| 9641K | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices (Enbrel, Nepexto) |
| 13332Q | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes (Enbrel) |
| 9615C | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes (Enbrel) |
Deletions
Deletion – Brand
| 12139X | Bosentan Mylan, AF– BOSENTAN , bosentan 62.5 mg tablet, 60 |
| 12143D | Bosentan Mylan, AF– BOSENTAN , bosentan 62.5 mg tablet, 60 |
| 12148J | Bosentan Mylan, AF– BOSENTAN , bosentan 62.5 mg tablet, 60 |
| 6429J | Bosentan Mylan, AF– BOSENTAN , bosentan 62.5 mg tablet, 60 |
| 11838C | Sevelamer Apotex, TX– SEVELAMER , sevelamer carbonate 800 mg tablet, 180 |
Deletion – Note
| 14189T | ANIFROLUMAB, anifrolumab 300 mg/2 mL injection, 2 mL vial (Saphnelo) |
Deletion – Restriction
| 14189T | ANIFROLUMAB, anifrolumab 300 mg/2 mL injection, 2 mL vial (Saphnelo) |
Alterations
Alteration – Note
| 14279M | ELEXACAFTOR + TEZACAFTOR + IVACAFTOR (&) IVACAFTOR, elexacaftor 80 mg + tezacaftor 40 mg + ivacaftor 60 mg granules [28] (&) ivacaftor 59.5 mg granules [28], 56 (Trikafta) |
| 14280N | ELEXACAFTOR + TEZACAFTOR + IVACAFTOR (&) IVACAFTOR, elexacaftor 100 mg + tezacaftor 50 mg + ivacaftor 75 mg granules [28] (&) ivacaftor 75 mg granules [28], 56 (Trikafta) |
| 13266F | ELEXACAFTOR + TEZACAFTOR + IVACAFTOR (&) IVACAFTOR, elexacaftor 50 mg + tezacaftor 25 mg + ivacaftor 37.5 mg tablet [56] (&) ivacaftor 75 mg tablet [28], 84 (Trikafta) |
| 12938Y | ELEXACAFTOR + TEZACAFTOR + IVACAFTOR (&) IVACAFTOR, elexacaftor 100 mg + tezacaftor 50 mg + ivacaftor 75 mg tablet [56] (&) ivacaftor 150 mg tablet [28], 84 (Trikafta) |
| 13326J | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices (Enbrel, Nepexto) |
| 9641K | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices (Enbrel, Nepexto) |
| 13332Q | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes (Enbrel) |
| 9615C | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes (Enbrel) |
Alteration – Restriction
| 14279M | ELEXACAFTOR + TEZACAFTOR + IVACAFTOR (&) IVACAFTOR, elexacaftor 80 mg + tezacaftor 40 mg + ivacaftor 60 mg granules [28] (&) ivacaftor 59.5 mg granules [28], 56 (Trikafta) |
| 14280N | ELEXACAFTOR + TEZACAFTOR + IVACAFTOR (&) IVACAFTOR, elexacaftor 100 mg + tezacaftor 50 mg + ivacaftor 75 mg granules [28] (&) ivacaftor 75 mg granules [28], 56 (Trikafta) |
| 13266F | ELEXACAFTOR + TEZACAFTOR + IVACAFTOR (&) IVACAFTOR, elexacaftor 50 mg + tezacaftor 25 mg + ivacaftor 37.5 mg tablet [56] (&) ivacaftor 75 mg tablet [28], 84 (Trikafta) |
| 12938Y | ELEXACAFTOR + TEZACAFTOR + IVACAFTOR (&) IVACAFTOR, elexacaftor 100 mg + tezacaftor 50 mg + ivacaftor 75 mg tablet [56] (&) ivacaftor 150 mg tablet [28], 84 (Trikafta) |
Highly Specialised Drugs Program (Public Hospital)
Additions
Addition – Item
| 14856X | MARIBAVIR, maribavir 200 mg tablet, 28 (Livtencity) |
Addition – Brand
| 13319B | Nepexto, GQ– ETANERCEPT , etanercept 50 mg/mL injection, 4 x 1 mL pen devices |
| 5735W | Nepexto, GQ– ETANERCEPT , etanercept 50 mg/mL injection, 4 x 1 mL pen devices |
Addition – Note
| 5734T | ETANERCEPT, etanercept 25 mg injection [4 vials] (&) inert substance diluent [4 x 1 mL syringes], 1 pack (Enbrel) |
Addition – Caution
| 13319B | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices (Enbrel, Nepexto) |
| 5735W | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices (Enbrel, Nepexto) |
| 13308K | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes (Enbrel) |
| 5733R | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes (Enbrel) |
Deletions
Deletion – Brand
| 12134P | Bosentan Mylan, AF– BOSENTAN , bosentan 62.5 mg tablet, 60 |
| 12140Y | Bosentan Mylan, AF– BOSENTAN , bosentan 62.5 mg tablet, 60 |
| 12145F | Bosentan Mylan, AF– BOSENTAN , bosentan 62.5 mg tablet, 60 |
| 5618Q | Bosentan Mylan, AF– BOSENTAN , bosentan 62.5 mg tablet, 60 |
| 11855Y | Sevelamer Apotex, TX– SEVELAMER , sevelamer carbonate 800 mg tablet, 180 |
Deletion – Note
| 14195D | ANIFROLUMAB, anifrolumab 300 mg/2 mL injection, 2 mL vial (Saphnelo) |
Deletion – Restriction
| 14195D | ANIFROLUMAB, anifrolumab 300 mg/2 mL injection, 2 mL vial (Saphnelo) |
Alterations
Alteration – Note
| 14227T | ELEXACAFTOR + TEZACAFTOR + IVACAFTOR (&) IVACAFTOR, elexacaftor 80 mg + tezacaftor 40 mg + ivacaftor 60 mg granules [28] (&) ivacaftor 59.5 mg granules [28], 56 (Trikafta) |
| 14228W | ELEXACAFTOR + TEZACAFTOR + IVACAFTOR (&) IVACAFTOR, elexacaftor 100 mg + tezacaftor 50 mg + ivacaftor 75 mg granules [28] (&) ivacaftor 75 mg granules [28], 56 (Trikafta) |
| 13276R | ELEXACAFTOR + TEZACAFTOR + IVACAFTOR (&) IVACAFTOR, elexacaftor 50 mg + tezacaftor 25 mg + ivacaftor 37.5 mg tablet [56] (&) ivacaftor 75 mg tablet [28], 84 (Trikafta) |
| 12936W | ELEXACAFTOR + TEZACAFTOR + IVACAFTOR (&) IVACAFTOR, elexacaftor 100 mg + tezacaftor 50 mg + ivacaftor 75 mg tablet [56] (&) ivacaftor 150 mg tablet [28], 84 (Trikafta) |
| 13319B | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices (Enbrel, Nepexto) |
| 5735W | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices (Enbrel, Nepexto) |
| 13308K | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes (Enbrel) |
| 5733R | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes (Enbrel) |
Alteration – Restriction
| 14227T | ELEXACAFTOR + TEZACAFTOR + IVACAFTOR (&) IVACAFTOR, elexacaftor 80 mg + tezacaftor 40 mg + ivacaftor 60 mg granules [28] (&) ivacaftor 59.5 mg granules [28], 56 (Trikafta) |
| 14228W | ELEXACAFTOR + TEZACAFTOR + IVACAFTOR (&) IVACAFTOR, elexacaftor 100 mg + tezacaftor 50 mg + ivacaftor 75 mg granules [28] (&) ivacaftor 75 mg granules [28], 56 (Trikafta) |
| 13276R | ELEXACAFTOR + TEZACAFTOR + IVACAFTOR (&) IVACAFTOR, elexacaftor 50 mg + tezacaftor 25 mg + ivacaftor 37.5 mg tablet [56] (&) ivacaftor 75 mg tablet [28], 84 (Trikafta) |
| 12936W | ELEXACAFTOR + TEZACAFTOR + IVACAFTOR (&) IVACAFTOR, elexacaftor 100 mg + tezacaftor 50 mg + ivacaftor 75 mg tablet [56] (&) ivacaftor 150 mg tablet [28], 84 (Trikafta) |
Highly Specialised Drugs Program (Community Access)
Additions
Addition – Item
| 14866K | MARIBAVIR, maribavir 200 mg tablet, 28 (Livtencity) |
Advance Notices
1 August 2025
Deletion – Brand
| 10310P | Tenofovir APOTEX, TX– TENOFOVIR DISOPROXIL , tenofovir disoproxil fumarate 300 mg tablet, 30 |
| 11992E | Tenofovir APOTEX, TX– TENOFOVIR DISOPROXIL , tenofovir disoproxil fumarate 300 mg tablet, 30 |
| 14637J | Emtricitabine and Tenofovir Disoproxil Fumarate 200 mg/300 mg Tablets (Laurus Labs, USA), KQ– TENOFOVIR DISOPROXIL + EMTRICITABINE , tenofovir disoproxil fumarate 300 mg + emtricitabine 200 mg tablet, 30 |
1 October 2025
Deletion – Brand
| 10348P | Lamivudine Alphapharm, AF– LAMIVUDINE , lamivudine 150 mg tablet, 60 |
| 10310P | Viread, GI– TENOFOVIR DISOPROXIL , tenofovir disoproxil fumarate 300 mg tablet, 30 |
| 11992E | Viread, GI– TENOFOVIR DISOPROXIL , tenofovir disoproxil fumarate 300 mg tablet, 30 |
Repatriation Pharmaceutical Benefits
Deletions
Deletion – Item
| 4571N | NICOTINE, nicotine 7 mg/24 hours patch, 7 (QuitX) |
| 4572P | NICOTINE, nicotine 14 mg/24 hours patch, 7 (QuitX) |
| 4573Q | NICOTINE, nicotine 21 mg/24 hours patch, 7 (QuitX) |
Deletion – Brand
| 4134N | Aldiq, AF– IMIQUIMOD , imiquimod 5% cream, 12 x 250 mg sachets |
| 4559Y | Aldiq, AF– IMIQUIMOD , imiquimod 5% cream, 12 x 250 mg sachets |
Advance Notices
1 August 2025
Deletion – Brand
| 4468E | Rynacrom, SW– CROMOGLYCATE , sodium cromoglycate 2% nasal spray, 26 mL |
Efficient Funding of Chemotherapy (Private Hospital)
Additions
Addition – Item
| 14860D |
NIVOLUMAB,
nivolumab 40 mg/4 mL injection, 4 mL vial (Opdivo) ; nivolumab 100 mg/10 mL injection, 10 mL vial (Opdivo) |
| 14872R |
NIVOLUMAB,
nivolumab 40 mg/4 mL injection, 4 mL vial (Opdivo) ; nivolumab 100 mg/10 mL injection, 10 mL vial (Opdivo) |
Addition – Brand
| 10763L | BENDAMUSTINE EUGIA, YG– BENDAMUSTINE , bendamustine hydrochloride 25 mg injection, 1 vial |
| 10763L | BENDAMUSTINE EUGIA, YG– BENDAMUSTINE , bendamustine hydrochloride 100 mg injection, 1 vial |
| 7249M | IRINOTECAN EUGIA, YG– IRINOTECAN , irinotecan hydrochloride trihydrate 100 mg/5 mL injection, 5 mL vial |
| 7249M | IRINOTECAN EUGIA, YG– IRINOTECAN , irinotecan hydrochloride trihydrate 500 mg/25 mL injection, 25 mL vial |
Deletions
Deletion – Brand
| 7229L | Adriamycin, PF– DOXORUBICIN , doxorubicin hydrochloride 200 mg/100 mL injection, 100 mL vial |
| 7249M | Omegapharm Irinotecan, OE– IRINOTECAN , irinotecan hydrochloride trihydrate 40 mg/2 mL injection, 2 mL vial |
| 7249M | Irinotecan Alphapharm, AF– IRINOTECAN , irinotecan hydrochloride trihydrate 100 mg/5 mL injection, 5 mL vial |
| 7249M | Omegapharm Irinotecan, OE– IRINOTECAN , irinotecan hydrochloride trihydrate 100 mg/5 mL injection, 5 mL vial |
| 7249M | Irinotecan Alphapharm, AF– IRINOTECAN , irinotecan hydrochloride trihydrate 500 mg/25 mL injection, 25 mL vial |
Alterations
Alteration – Manufacturer Code
| From | To | ||
| 10383L | Kanjinti– TRASTUZUMAB , trastuzumab 420 mg injection, 1 vial | JU | XT |
| 10402L | Kanjinti– TRASTUZUMAB , trastuzumab 420 mg injection, 1 vial | JU | XT |
| 10589H | Kanjinti– TRASTUZUMAB , trastuzumab 420 mg injection, 1 vial | JU | XT |
| 10597R | Kanjinti– TRASTUZUMAB , trastuzumab 420 mg injection, 1 vial | JU | XT |
| 7264H | Kanjinti– TRASTUZUMAB , trastuzumab 420 mg injection, 1 vial | JU | XT |
| 7265J | Kanjinti– TRASTUZUMAB , trastuzumab 420 mg injection, 1 vial | JU | XT |
| 7266K | Kanjinti– TRASTUZUMAB , trastuzumab 420 mg injection, 1 vial | JU | XT |
| 7267L | Kanjinti– TRASTUZUMAB , trastuzumab 420 mg injection, 1 vial | JU | XT |
Advance Notices
1 August 2025
Deletion – Brand
| 10699D | Arsenic Trioxide-AFT, AE– ARSENIC , arsenic trioxide 10 mg/10 mL injection, 10 x 10 mL ampoules |
| 7241D | Arsenic Trioxide-AFT, AE– ARSENIC , arsenic trioxide 10 mg/10 mL injection, 10 x 10 mL ampoules |
| 12219D | Bortezomib Sandoz, SZ– BORTEZOMIB , bortezomib 3.5 mg injection, 1 vial |
| 7234R | Fluorouracil Ebewe, SZ– FLUOROURACIL , fluorouracil 1 g/20 mL injection, 20 mL vial |
| 7234R | Fluorouracil Ebewe, SZ– FLUOROURACIL , fluorouracil 5 g/100 mL injection, 100 mL vial |
| 7239B | Fluorouracil Ebewe, SZ– FLUOROURACIL , fluorouracil 1 g/20 mL injection, 20 mL vial |
| 7239B | Fluorouracil Ebewe, SZ– FLUOROURACIL , fluorouracil 5 g/100 mL injection, 100 mL vial |
Efficient Funding of Chemotherapy (Public Hospital)
Additions
Addition – Item
| 14855W |
NIVOLUMAB,
nivolumab 40 mg/4 mL injection, 4 mL vial (Opdivo) ; nivolumab 100 mg/10 mL injection, 10 mL vial (Opdivo) |
| 14859C |
NIVOLUMAB,
nivolumab 40 mg/4 mL injection, 4 mL vial (Opdivo) ; nivolumab 100 mg/10 mL injection, 10 mL vial (Opdivo) |
Addition – Brand
| 10760H | BENDAMUSTINE EUGIA, YG– BENDAMUSTINE , bendamustine hydrochloride 25 mg injection, 1 vial |
| 10760H | BENDAMUSTINE EUGIA, YG– BENDAMUSTINE , bendamustine hydrochloride 100 mg injection, 1 vial |
| 4451G | IRINOTECAN EUGIA, YG– IRINOTECAN , irinotecan hydrochloride trihydrate 100 mg/5 mL injection, 5 mL vial |
| 4451G | IRINOTECAN EUGIA, YG– IRINOTECAN , irinotecan hydrochloride trihydrate 500 mg/25 mL injection, 25 mL vial |
Deletions
Deletion – Brand
| 4361M | Adriamycin, PF– DOXORUBICIN , doxorubicin hydrochloride 200 mg/100 mL injection, 100 mL vial |
| 4451G | Omegapharm Irinotecan, OE– IRINOTECAN , irinotecan hydrochloride trihydrate 40 mg/2 mL injection, 2 mL vial |
| 4451G | Irinotecan Alphapharm, AF– IRINOTECAN , irinotecan hydrochloride trihydrate 100 mg/5 mL injection, 5 mL vial |
| 4451G | Omegapharm Irinotecan, OE– IRINOTECAN , irinotecan hydrochloride trihydrate 100 mg/5 mL injection, 5 mL vial |
| 4451G | Irinotecan Alphapharm, AF– IRINOTECAN , irinotecan hydrochloride trihydrate 500 mg/25 mL injection, 25 mL vial |
Alterations
Alteration – Manufacturer Code
| From | To | ||
| 10391X | Kanjinti– TRASTUZUMAB , trastuzumab 420 mg injection, 1 vial | JU | XT |
| 10401K | Kanjinti– TRASTUZUMAB , trastuzumab 420 mg injection, 1 vial | JU | XT |
| 10581X | Kanjinti– TRASTUZUMAB , trastuzumab 420 mg injection, 1 vial | JU | XT |
| 10588G | Kanjinti– TRASTUZUMAB , trastuzumab 420 mg injection, 1 vial | JU | XT |
| 4632T | Kanjinti– TRASTUZUMAB , trastuzumab 420 mg injection, 1 vial | JU | XT |
| 4639E | Kanjinti– TRASTUZUMAB , trastuzumab 420 mg injection, 1 vial | JU | XT |
| 4650R | Kanjinti– TRASTUZUMAB , trastuzumab 420 mg injection, 1 vial | JU | XT |
| 4703M | Kanjinti– TRASTUZUMAB , trastuzumab 420 mg injection, 1 vial | JU | XT |
Advance Notices
1 August 2025
Deletion – Brand
| 10691Q | Arsenic Trioxide-AFT, AE– ARSENIC , arsenic trioxide 10 mg/10 mL injection, 10 x 10 mL ampoules |
| 4371C | Arsenic Trioxide-AFT, AE– ARSENIC , arsenic trioxide 10 mg/10 mL injection, 10 x 10 mL ampoules |
| 12227M | Bortezomib Sandoz, SZ– BORTEZOMIB , bortezomib 3.5 mg injection, 1 vial |
| 4394G | Fluorouracil Ebewe, SZ– FLUOROURACIL , fluorouracil 1 g/20 mL injection, 20 mL vial |
| 4394G | Fluorouracil Ebewe, SZ– FLUOROURACIL , fluorouracil 5 g/100 mL injection, 100 mL vial |
| 4431F | Fluorouracil Ebewe, SZ– FLUOROURACIL , fluorouracil 1 g/20 mL injection, 20 mL vial |
| 4431F | Fluorouracil Ebewe, SZ– FLUOROURACIL , fluorouracil 5 g/100 mL injection, 100 mL vial |
Related Pharmaceutical Benefits for Public Hospital use
Advance Notices
1 August 2025
Deletion – Brand
| 5899L | Granisetron-AFT, AE– GRANISETRON , granisetron 3 mg/3 mL injection, 3 mL ampoule |
1 October 2025
Deletion – Brand
| 5857G | Ondansetron Mylan ODT, AF– ONDANSETRON , ondansetron 4 mg orally disintegrating tablet, 4 |
